attyloid becomes an Alamar Certified Service Provider for NULISA™
attyloid has been certified by Alamar Biosciences as an official Certified Service Provider (CSP) for NULISA™ assays on the ARGO® HT platform.
The certification recognizes that our laboratory, technical expertise and analytical workflows meet Alamar’s standards for providing high-quality NULISA™ services to research and biopharmaceutical partners.
Becoming a Certified Service Provider is therefore an important milestone for attyloid. Following implementation of the ARGO® HT platform and training of our team, the certification formally qualifies us to provide NULISA™ analysis as part of our bioanalytical services.
For our partners, this means access to NULISA™ through a qualified service laboratory with experience in translational biomarker studies and preclinical and clinical drug development.
We see particular value in combining NULISA™ with our established sFIDA® oligomer biomarkers in CNS drug development. At the same time, NULISA™ allows us to support biomarker studies across additional disease areas, including inflammation, immunology and cardiovascular research.
We are already applying NULISA™ in our project work and look forward to expanding its use together with our partners.
Interested in discussing a NULISA™ study? Please get in touch with our team.